Human LILRB4/CD85k/ILT3 Domain1&2 Protein, Accession: AAH26309

/在： /经由过程：
  • 产物概述
  • 产物规格
  • 运输及存储
  • 品牌申明

    • 产物概述

    产物描写

    Recombinant Human LILRB4/CD85k/ILT3 Domain1&2 Protein is expressed from HEK293 with His tag at the C-terminal.It contains Pro27-Ser218.

    Biotinylated

    产物规格

    靶点

    LILRB4/CD85k/ILT3 Domain1&2

    份子又名

    HM18; ILT3; ILT-3; LILRB4; LIR5; CD85K

    Accession

    种属

    Human

    卵白序列

    Pro27-Ser218

    份子量

    The protein has a predicted MW of 22.9 kDa. Due to glycosylation, the protein migrates to 23-25 kDa based on Tris-Bis PAGE result.

    活性

    Immobilized Human LILRB4 Domain 1&2, His Tag at 2ug/ml (100ul/Well) on the plate. Dose response curve for Anti-LILRB4 Antibody, hFc Tag with the EC50 of 18.2ng/ml determined by ELISA. See testing image for detail.

    产物标签

    C-His

    抒发体系

    HEK293

    纯度

    > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC

    内毒素

    Less than 1EU per ug by the LAL method.

    运输及存储

    产物表面

    Liquid

    运输前提

    Shipped with blue ice.

    制剂

    Supplied as 0.22um filtered solution in 20mM Tris, 150mM NaCl (pH 8.2).

    复溶

    存储和不变性

    Valid for 12 months from date of receipt when stored at -80°C.； Recommend to aliquot the protein into smaller quantities for optimal storage. Please avoid repeated freeze-thaw cycles. 该物质的品脾ChemWhat是Watson的公司注册钢种，由Watson受权山东海角社区 在中国现代大陆地区采用，点此拜候。